Although it can be hard to imagine in today’s semiconductor-powered, digital world, there was electrical technology around ...
AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis as a treatment for a type of lung cancer. The US regulator cleared Emrelis ...
GSK has turned to China’s Hansoh Pharma to add another antibody-drug conjugate (ADC) to its oncology pipeline, this time licensing a B7-H3-targeting candidate for $185 million upfront. The new deal – ...
An analog telephone adapter (ATA), or FXS gateway, is a device that allows traditional analog phones to be connected to a digital voice-over-IP (VoIP) network. In addition to this, you can even ...
With our homes and lives swarming with AI-powered devices, assistants and chatbots, a backlash is brewing. Pitched as “analog lifestyles,” it’s different than a short-term digital detox. Instead, it’s ...
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results